NCT05077709 · Interventional trial
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC
Overall registry status Completed
Phase 2
Conditions Head and Neck Squamous Cell Carcinoma, Lung Cancer Non Small Cell, Urothelial Carcinoma Bladder
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory